First Presentations News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Visual Communications Platform Canva Announces USD 15 Billion Valuation; Launches Suite of Presentations Products for the Workplace on April 07 2021 5:02 AM More than 85% of the Fortune 500 Embrace Canva to Bolster Collaboration and Productivity, with over 250 million Presentations Created SYDNEY--(BUSINESS WIRE)--Canva, the global visual communications platform, today announced an updated valuation of USD 15 billion following a USD 71 million investment. This latest valuation affirms Canva as one of the fastest-growing software companies in history, surpassing $500 million annualized revenue...

FDA Approves Libtayo® as Monotherapy for Advanced NSCLC Search jobs Subject: FDA Approves Libtayo     Regeneron and Sanofi received U.S. FDA approval for Libtayo® (cemiplimab-rwlc, an PD-1 inhibitor) for the first-line treatment of patients with advanced non-small cell lung cancer (NSCLC) whose tumors have high PD-L1 expression (tumor proportion score ≥50%), %), as determined by an FDA-approved test. Patients must either have metastatic or locally advanced tumors that are not candidates for surgical resection or definitive chemoradiation, and the tumors must not have EGFR, ALK or ROS1 ...